I tested the Streamlights PROTAC HL® 4 HIGH LUMEN TACTICAL LIGHT, a dual power hand torch that throws can throw a beam out to 346 meters. The PROTAC HL® 4 is 8.63 inches long and weighs 1.1 lbs. It is ...
Company to highlight new safety, pharmacokinetic, and pharmacodynamic data from Phase 1 clinical trial of ARV-102 in participants with ...
Engineers at Duke University have demonstrated a technique that uses microbubbles and ultrasound to help relatively large cancer drugs enter tumor cells and cause them to self-destruct. Dubbed ...
Cancer therapies sometimes involve drugs that mediate the breakdown of specific intracellular proteins that participate in cancer formation and proliferation. Proteolysis-targeting chimeras or PROTACs ...
NEW HAVEN, Conn., June 21, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ...
The PROTAC market is experiencing rapid growth, driven by rising interest in targeted protein degradation as a next-generation therapeutic approach. Expanding oncology pipelines with drugs in clinical ...
Cancer therapies sometimes involve drugs that mediate the breakdown of specific intracellular proteins that participate in cancer formation and proliferation. Proteolysis-targeting chimeras or PROTACs ...
EAGLEVILLE, PA - Streamlight Inc., a leading provider of high-performance lighting, introduced the ProTac 2.0 HP tactical flashlight, delivering 85,000 candela for powerful downrange illumination, ...
** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** Boasting 2,000 lumens on its high ...
The ProTac HL® 6 tactical light from Streamlight delivers up to 5,300 lumens. EAGLEVILLE, PA, July 1, 2024 - Streamlight® Inc., a leading provider of high-performance lighting and weapon light/laser ...
Proteolysis Targeting Chimeras (PROTACs) are a novel approach for degrading target proteins. Recently, a new split-and-mix PROTAC (SM-PROTAC) system based on liposome self-assembly, known as ...
Researchers have developed an improved type of PROTAC that has enhanced intracellular accumulation and functions, not only as a degrader, but also as an inhibitor of the target protein. Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results